We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with the Stevanato Group to help solve a serious problem facing vaccine manufacturers as they scale up production — a global shortage of glass vials. Read More
Catalent will also provide clinical supply services from its facilities in Philadelphia to support Moderna’s phase 3 clinical trial of the vaccine. Read More
Demand for the corticosteroid dexamethasone has skyrocketed in the days since the University of Oxford published trial results suggesting the drug could be a game-changer for treating severely ill COVID-19 patients, hospital data shows. Read More
Gilead Sciences has signed four more non-exclusive licensing agreements with generic drugmakers to make remdesivir available to COVID-19 patients in low-income countries. Read More
Corvidia’s shareholders will receive an upfront payment of $725 million and will be eligible for future payments that could total $2.1 billion. Read More